Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Middleton P; ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, 72 King William Road, Adelaide, South Australia, Australia, 5006.; Crowther CA
Subjects: Diabetes, Gestational* ; Reminder Systems*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*diagnosis
-
Source:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2014 Mar 18 (3). Cochrane AN: CD009578. Date of Electronic Publication: 2014 Mar 18.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet
Record details
-
Authors :
Tan GSQ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy
-
Source:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1304-1315. Date of Electronic Publication: 2024 Feb 09.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications
-
Source:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet
Record details
-
Authors :
Wei J; Department of Orthopaedics, Xiangya Hospital, Central South University, Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Hunan Key Laboratory of Joint Degeneration and Injury, and Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.; Hunter D
Subjects: Osteoarthritis, Hip*/Osteoarthritis, Hip*/Osteoarthritis, Hip*/etiology ; Diabetes Mellitus, Type 2* ; Osteoarthritis, Knee*/Osteoarthritis, Knee*/Osteoarthritis, Knee*/complications
-
Source:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Apr; Vol. 76 (4), pp. 577-586. Date of Electronic Publication: 2023 Dec 06.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Holloway D; School of Nursing, Midwifery and Paramedicine, University of the Sunshine Coast, Caboolture, Queensland, Australia.; James S
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy ; Diabetes Mellitus, Type 1*; Adult
-
Source:
International journal of nursing practice [Int J Nurs Pract] 2023 Dec; Vol. 29 (6), pp. e13135. Date of Electronic Publication: 2023 Feb 02.Publisher: Wiley Country of Publication: Australia NLM ID: 9613615 Publication Model:
Record details
-
Authors :
Zheng J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, and Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the People's Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, and MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK.; Wheeler E
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/complications
-
Source:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Oct; Vol. 75 (10), pp. 1781-1792. Date of Electronic Publication: 2023 Aug 03.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:
Record details
